Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |